Truist Reduces PT on American Healthcare REIT (AHR) Stock

American Healthcare REIT, Inc. (NYSE:AHR) is one of the High-Flying Stocks to Buy Right Now. On January 20, Truist analyst Michael Lewis reduced its price objective on the company’s stock to $52 from $53, while keeping a “Buy” rating, as reported by The Fly. Notably, the firm made adjustments in the ratings and targets across the broader real estate investment trust group in relation to the 2026 outlook.

Furthermore, the firm is “Neutral” on REITs for 2026. It highlighted that the fundamentals have been improving amidst slowing new supply as well as steady demand when it comes to high-quality assets.

That being said, the analyst believes that the stocks are not particularly cheap. Overall, the firm remains relatively bullish on healthcare, industrial, strip retail, gaming, and lodging REITs. It is neutral on manufactured housing, multifamily, self-storage, and triple net. However, Truist is relatively cautious on mall and office.

In a different release, Michael Goldsmith from UBS maintained a “Buy” rating on American Healthcare REIT, Inc. (NYSE:AHR)’s stock with a price objective of $56.00.

American Healthcare REIT, Inc. (NYSE:AHR) is a real estate investment trust that acquires, owns, and operates a diversified portfolio of clinical healthcare real estate.

While we acknowledge the potential of AHR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now

Disclosure: None. This article is originally published at Insider Monkey.